Found 50 matching trials
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia PHASE2 The purpose of this study is to compare the efficacy and safety of venetocl...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML PHASE2 This investigator-initiated, single-arm, phase II trial is aimed to evaluat...
Show More Location
Ethical Committee of the First Affiliated Hospital of Soochow University
Learn More & Join Trial
Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients PHASE3 Combining the results of previous studies and based on the clinical practic...
Show More Location
The Second Affiliated Hospital of Kunming Medical University.
Learn More & Join Trial
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) PHASE3 The purpose of this study is to assess how bleximenib and Venetoclax (VEN)+...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR) PHASE2 Open-label phase II, single arm, multicenter study with safety run-in to ev...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia PHASE2 This study is to investigate the therapeutic efficacy and side effect of ve...
Show More Location
The First Affliated Hospital of Soochow University
Learn More & Join Trial
Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven NA The study proposes to correlate the plasma dosage of VEN with the inhibitio...
Show More Location
Hopital la Conception
Learn More & Join Trial
Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT PHASE2 The purpose of this prospective, open-label, single-center study is to eval...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML PHASE1 To assess safety and tolerability at increasing dose levels of IO-202 in su...
Show More Location
University California, Davis (117)
Learn More & Join Trial
Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN PHASE2 This is a single-center randomized phase 2 open-label clinical trial....
Location
Virginia Commonwealth University
Learn More & Join Trial